Quality of life (QOL) has become an increasingly popular outcome measure in healthcare during the past 20 years. Despite its growing popularity, there is no professional agreement regarding definitions, conceptual models, or instrumentation. Many patient populations have been studied, but there has been minimal investigation of health-related QOL in patients receiving homecare, especially home infusion services. This study, which used the Ferrans and Powers Cancer Index III, explored QOL in cancer patients receiving home infusion therapies for at least 30 days. Although no statistically significant improvements in QOL were identified, the study was useful in pinpointing relevant issues for future QOL investigation in homecare and home infusion.
Marilyn Hanchett was the Director of Performance Improvement at the corporate office of Express Scripts Infusion Services, St. Louis, Missouri, at the time of this study. She is currently employed within the University of Missouri Health Care System, Columbia, Missouri.
Address correspondence and reprint requests to: Marilyn Hanchett, Columbia Regional Hospital, University of Missouri Health Care, 404 Keene Street, Columbia, MO 65201 (e-mail: email@example.com).
This study was funded by the 1998 Johnson & Johnson Medical, Inc. Research Grant through the Gardner Foundation.